Novartis, which is a world-leading innovative medicines company, has gone ahead and announced its plans on January 09, 2026, to build its fourth US radioligand therapy – RLT manufacturing facility at Florida’s Winter Park. This built-for-purpose and state-of-the-art facility is another milestone in the $23bn US investment that the company announced in April 2025, thereby […]
